Naltrexon Accord (Naltrexone Hydrochloride)

Naltrexone works by competitively binding to mu‑opioid receptors in the central nervous system without activating them. This blocks the action of both endogenous opioids and external opioid substances, decreasing the rewarding sensations and reducing the physiological drive to consume alcohol or opioids.

The specific dose of Naltrexon Accord is determined by the prescribing clinician based on the individual’s medical condition, response, and any concomitant therapies. Patients should follow the dosage instructions provided by their healthcare professional and not adjust the dose on their own.

Safety data for naltrexone in pregnancy and lactation are limited. The drug should only be used if the potential benefit outweighs the possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and risks with their healthcare provider.

To request Naltrexon Accord, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and import documentation.

For alcohol dependence, alternatives such as acamprosate or disulfiram have different mechanisms—acamprosate modulates glutamate, while disulfiram inhibits aldehyde dehydrogenase. In opioid dependence, methadone and buprenorphine act as opioid agonists or partial agonists, whereas naltrexone is a pure antagonist, offering a non‑opioid approach that blocks relapse without providing opioid effects.

Naltrexon Accord should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

The medication is taken orally, usually as a tablet, and should be swallowed whole with a glass of water. It is typically taken once daily, but the exact schedule is set by the prescribing clinician based on the therapeutic plan.

Serious risks include hepatotoxicity, which may present as elevated liver enzymes or hepatitis, and severe allergic reactions such as anaphylaxis. Additionally, patients may experience depression or suicidal thoughts, so monitoring mental health status throughout treatment is essential.

Naltrexon Accord is contraindicated in individuals currently using opioid analgesics or in acute opioid withdrawal, as it can precipitate severe withdrawal symptoms. Patients with severe hepatic impairment or known hypersensitivity to naltrexone or any excipients should also avoid using this medication.